Home

LUNGevity is transforming how people are diagnosed and live with lung cancer through research, education, and support.

Screening for
Lung Cancer

I Am a Patient, Survivor, or Caregiver

I Am a Supporter, Advocate, or Donor

Latest News & Blogs

Latest Blog and News Tom and Mary Lynn Moser smiling in the mountains

Advice from a Former Caregiver

Read time: 3 minutes Tom Moser wrote the words below based on years of experience caring for his wife, Mary Lynn, who had lung and breast cancer and has since passed away. Prior to her passing, Mary Lynn authored a separate blog encouraging readers to be both mentees and mentors, as

Latest Blog and News Mary Lynn Moser giving a thumbs up

Mary Lynn’s Message: Be More than a Survivor, Be a Thriver

Read time: 3 minutes Mary Lynn Moser, with her husband and caregiver, Tom, wrote the words below before her passing. She was a supporter of LUNGevity and served as a mentor to others experiencing lung cancer. Her message encourages others to be “thrivers” and mentors in their lung

Latest Blog and News American Lung Association and LUNGevity Foundation Announce $3 Million Research Partnership to Intercept Lung Cancer

WASHINGTON, DC (April 9, 2024) – Lung cancer remains the leading cause of cancer deaths in the United States, with someone diagnosed approximately every two minutes.

Latest Blog and News Sean Swarner smiling while backpacking

Meet HOPE Summit Keynote Speaker Sean Swarner

Read time: 2 minutes Sean Swarner is taking the stage Saturday, May 4, to kick off HOPE Summit 2024. He’s a two-time cancer survivor—diagnosed at 13 and 16 years old—and each time was told he only had months or weeks to live. But at 27 he climbed Mt. Everest with just one lung and later

Latest Blog and News Headshot of Dr. Coral Olazagasti

Working to Diagnose Lung Cancer Earlier in Hispanic Communities

Read time: 4 minutes Lung cancer screening guidelines were first issued by the United States Preventive Services Task Force in 2013 to help doctors find lung cancer in its earliest stages when it is most treatable, and often curable. Since then, the eligibility guidelines have been revised

Latest Blog and News Logo of grand cancer challenges

Cancer Grand Challenges Summit 2024: No Time to Waste in Addressing Some of Toughest Challenges in Cancer

Read time: 4 minutes I just returned from the Cancer Grand Challenges Summit, held March 5–8, 2024 in London, England. Cancer Grand Challenges was launched in 2020 as a collaboration between Cancer Research UK and the National Cancer Institute in the US, whereby they provide $25 million to

Latest Blog and News Lynne Doughtie

Former KPMG Chairman and CEO Lynne Doughtie Assumes Role as Chair of LUNGevity’s Board of Directors

WASHINGTON, DC (March 21, 2024) – LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, announced today the appointment of Lynne Doughtie, former KPMG chairman and CEO, as chair of its Board of Directors.

Latest Blog and News Dr. Jaclyn LoPiccolo headshot

Leveraging Genetics to Understand Why Younger Adults Are Developing Lung Cancer

Read Time: 5 minutes It’s a mystery that has been baffling researchers: Why do some people develop lung cancer in their 20s or 30s? While we used to think lung cancer was only caused by exposure to tobacco and environmental factors like radon, researchers are starting to learn that the

Latest Blog and News HOPE Summit 2024 logo

New Family Resources at HOPE Summit

Read time: 2 minutes HOPE Summit is LUNGevity’s annual in-person conference that combines education and connection for people affected by lung cancer. Hundreds of people from across the country come together to create their own community of support and hear from expert speakers on

Latest Blog and News Dr. Angel Qin headshot

From Leukemia to ALK+ NSCLC: Finding a New Way to Overcome Drug Resistance

Read Time: 5 minutes Approximately 4% of patients diagnosed with non-small cell lung cancer (NSCLC) will have their tumors test positive for an ALK biomarker. This means the ALK gene in the tumor cells has fused with another gene (most commonly EML4). This fusion produces a

Latest Blog and News Photo of special guest Monica Popp

Advocacy and Policy: What to Expect in Washington in 2024

Read Time: 2 minutes The LUNGevity Action Network was joined by Monica Popp for a conversation about what’s happening in Washington, DC, this election year. Monica is a political strategist specializing in health policy, and she talked with us about these timely topics:

Latest Blog and News Close up headshot of Dr. Reuben

Using T cells to Tackle Drug Resistance in EGFR+ Lung Cancer

Approximately 10%-15% of patients with non-small cell lung cancer have tumors with mutations in the EGFR (epidermal growth factor receptor) gene. EGFR mutations are known to drive cancer growth. Many patients living with EGFR-positive lung cancer benefit from targeted therapies called tyrosine

Support Our Work

Your support will help drive advances in lung cancer detection and treatment that are saving lives, and provide free education and support to all affected by lung cancer. Make a tax-deductible donation now, or fundraise with LUNGevity!

DONATE NOW

Resources

LUNGevity has tools and resources to help manage life after lung cancer diagnosis.

LEARN MORE

Gateways

The Patient Gateways are a hub for information and resources related to your specific type of lung cancer.

LEARN MORE

Events

LUNGevity offers conferences, survivorship summits, fundraising and awareness events, and more.

LEARN MORE

Home

Screening for
Lung Cancer

I Am a Patient, Survivor, or Caregiver

I Am a Supporter, Advocate, or Donor

Latest News & Blogs

Support Our Work

Resources

Gateways

Events

LUNGevity Foundation

CHICAGO OFFICE

BETHESDA OFFICE

MAILING ADDRESS

Home

Screening for Lung Cancer

I Am a Patient, Survivor, or ​Caregiver

I Am a Supporter, ​Advocate, or Donor

Latest News & Blogs

Support Our Work

Resources

Gateways

Events

CHICAGO OFFICE

BETHESDA OFFICE

MAILING ADDRESS

Screening for
Lung Cancer

I Am a Patient, Survivor, or Caregiver

I Am a Supporter, Advocate, or Donor